Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Operating Expenses (2016 - 2025)

Vycor Medical has reported Operating Expenses over the past 16 years, most recently at $371895.0 for Q4 2025.

  • Quarterly Operating Expenses fell 1.62% to $371895.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 6.67% year-over-year, with the annual reading at $1.5 million for FY2025, 6.67% up from the prior year.
  • Operating Expenses was $371895.0 for Q4 2025 at Vycor Medical, down from $419847.0 in the prior quarter.
  • Over five years, Operating Expenses peaked at $474121.0 in Q1 2021 and troughed at $296987.0 in Q1 2023.
  • The 5-year median for Operating Expenses is $367732.5 (2025), against an average of $365870.1.
  • Year-over-year, Operating Expenses dropped 29.7% in 2022 and then grew 28.98% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $406144.0 in 2021, then decreased by 19.9% to $325309.0 in 2022, then grew by 1.53% to $330285.0 in 2023, then rose by 14.46% to $378038.0 in 2024, then fell by 1.62% to $371895.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Operating Expenses are $371895.0 (Q4 2025), $419847.0 (Q3 2025), and $364125.0 (Q2 2025).